Favourable outcome for patients with myeloid disorders treated with fludarabine-melphalan reduced-intensity conditioning and allogeneic bone marrow stem cell transplantation without the use of T-lymphocyte-depleting antibodies-Reference-Cited by-同舟云学术

Favourable outcome for patients with myeloid disorders treated with fludarabine-melphalan reduced-intensity conditioning and allogeneic bone marrow stem cell transplantation without the use of T-lymphocyte-depleting antibodies

Published:2004-07-09 Issue:2 Volume:73 Page:85-92
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:

Author:

Malladi R. K.,Peniket A. J.,Norton A. E.,Campbell A. J.,Collins G. P.,Samol J.,Eagleton H.,Miller E.,Morgenstern G.,Jones J.,Keen-Mcguire A.,Barnardo M.,Littlewood T. J.

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.2004.00266.x/fullpdf

Reference38 articles.

1. Prognostic factors in elderly patients with acute myeloid leukaemia;Johnson;Leuk Lymphoma,1994

2. Rapid achievement of complete donor chimerism and low regimen-related toxicity after reduced conditioning with fludarabine, carmustine, melphalan and allogeneic transplantation;Wasch;Bone Marrow Transplant,2000

3. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses;Childs;Blood,1999

4. Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen;Morecki;Bone Marrow Transplant,2001

5. Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders;Perez-Simon;Blood,2002

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fifty Years of Melphalan Use in Hematopoietic Stem Cell Transplantation;Biology of Blood and Marrow Transplantation;2013-03

2. Nonmyeloablative and Reduced-Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation;American Journal of Clinical Oncology;2009-12

3. The allogeneic graft-versus-cancer effect;British Journal of Haematology;2009-09-04

4. The evolution of hematopoietic SCT in myelodysplastic syndrome;Bone Marrow Transplantation;2009-03-02

5. Allogeneic transplantation for myelodysplastic syndrome (MDS);Blood Reviews;2007-03